Contact Levi & Korsinsky by March 4, 2025 Deadline to Join Class Action Against Revance Therapeutics, Inc. (RVNC)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 04 2025
0mins
Source: Globenewswire
Class Action Lawsuit: Levi & Korsinsky, LLP has initiated a class action lawsuit against Revance Therapeutics, Inc. for alleged securities fraud affecting investors between February 29, 2024, and December 6, 2024.
Investor Participation: Investors who suffered losses during this period can request to be appointed as lead plaintiff by March 4, 2025, with no out-of-pocket costs required to participate in the lawsuit.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
